Clinical grade virus vectors

Ended Purchase Order Awarded

Contract number
75N93018P01294
Awardee
Awarding agency
Obligated
$664,001

Award facts

Opportunity
Contract value 100% obligated
$664,000.65 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Not Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Rockville, MD 20850, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Modification $665,000
Funding Only Action P00001 -$999

About this award

The National Institute of Allergy and Infectious Diseases (NIAID), part of the Department of Health and Human Services (HHS), awarded a $664,000.65 firm fixed price purchase order to Vigene Biosciences, Inc., a minority-owned small business, for the delivery of clinical grade virus vectors. The award was made through a sole source acquisition process under Federal Acquisition Regulation (FAR) Part 12 for commercial items. The vectors are needed to support ongoing research at NIAID's Laboratory of Clinical Immunology and Microbiology. No set-aside was used for this award.

Quick answers

Who was awarded contract 75N93018P01294?

75N93018P01294 was awarded to Vigene Biosciences, Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on September 12, 2018.

How much is contract 75N93018P01294 worth?

The government has obligated $664,001 on 75N93018P01294.

Was contract 75N93018P01294 competed?

The extent of competition for 75N93018P01294 was not competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award